Outbreak of Norovirus Infection in the Hematology Department of a Children's Multidisciplinary Hospital
https://doi.org/10.31631/2073-3046-2024-23-6-73-82
Abstract
Relevance. Noroviruses are currently considered the most common cause of sporadic cases and community-acquired outbreaks of acute gastroenteritis (AGE) worldwide [1]. However, outbreaks of healthcare-associated infections (HAI) are also often caused by norovirus etiology [2], including in the Russian Federation [3].
Aim. Analysis of key aspects of prevention and anti-epidemic measures against norovirus infection (NVI) in the hematology department.
Materials and methods. The following epidemiological research methods were used: descriptive (intensity, dynamics, spatial characteristics of the NVI outbreak); analytical – longitudinal cohort study of the epidemic process of HAI – assessment of hypotheses about the causes and conditions, risk factors and routes of transmission of norovirus among patients and caregivers in the oncohematology department of the children's multidisciplinary hospital.
Results and discussion. An outbreak of acute norovirus gastroenteritis of an imported nature was identified in the oncohematology department of a children's multidisciplinary hospital in February 2023, an analysis of the spread of NVI was carried out: the presumed source and mechanism of transmission of norovirus infection was established; the chronology of the spread of norovirus among patients and their caregivers is shown, a list of anti-epidemic measures taken to stop the outbreak is presented, and the difficulties of verifying the epidemiological diagnosis of HAI are reflected (based on the efficiency of laboratory testing of material from patients).
Conclusion. Based on the results of the activities carried out, recommendations were proposed for improving preventive and anti-epidemic measures for acute gastroenteritis (AGE) in children's oncohematology departments.
About the Authors
M. A. DavydovaRussian Federation
Maria A. Davydova – head of department, doctor-epidemiologist, postgraduate student of the 3t year students of department of infectious diseases and epidemiology of faculty of advanced training and retraining faculty
Krasnodar
+7 (918) 997-33-57
G. D. Bryukhanova
Russian Federation
Galina D. Bryukhanova – Dr. Sci. (Med.), Professor of department of infectious diseases and epidemiology of faculty of advanced training and retraining faculty
Krasnodar
+7 (918) 919-67-81
V. N. Gorodin
Russian Federation
Vladimir N. Gorodin – Dr. Sci. (Med.), Professor, Head of the Department of Infectious Diseases and Epidemiology
Krasnodar
+7 (861) 255-44-23
References
1. Khokhlova N.I., Kapustin D.V., Krasnova E.I., et al. Norovirus infection (literature review). Journal of Infectology. 2018; 10(1): 5–14 (In Russ.). https://doi.org/10.22625/2072-6732-2018-10-1-5-14 (дата обращения 29.01.2024).
2. Sandmann F.G., Shallcross L., Adams N. et al. Estimating the Hospital Burden of Norovirus-Associated Gastroenteritis in England and Its Opportunity Costs for Nonadmitted Patients. Clin. Infect. Dis. 2018, 67, 693–700
3. On the state of sanitary and epidemiological welfare of the population in the Russian Federation in 2022: State Report. Moscow: Federal Service for Supervision of Consumer Rights Protection and Human Well-being, 2023. 368 p. (In Russ.).
4. Winder N., Gohar S., Muthana M. Norovirus: An Overview of Virology and Preventative Measures. Viruses 2022, 14, 2811, 21 р. https://doi.org/10.3390/v14122811.
5. Hall AJ., Lopman B.A., Payne D.C., et al. Norovirus disease in the United States. Emerg Infect Dis.2013;19:1198–1205.
6. Trivedi T.K., DeSalvo T., Lee L., et al. Hospitalizations and mortality associated with norovirus outbreaks in nursing homes, 2009 – 2010. J. Am. Med. Assoc. 2012; 308: 1668–1675.
7. Robilotti E., Deresinski S., Pinsky B.A.//Norovirus// Clin. Microbiol. Rev. 2015; 28: 134–164.
8. Newman K.L., Moe C.L., Kirby A.E., et al. Norovirus in symptomatic and asymptomatic individuals: cytokines and viral shedding. Clin. Exp. Immunol.2016;184: =347–357.
9. Payne D.C., Vinjé J., Szilagyi P.G., et al. Norovirus and medically attended gastroenteritis in US children//N.Engl. J. Med. 2013;368:1121–30.
10. Haddadin Z., Batarseh E., Hamdan L., et al. Characteristics of GII.4 Norovirus Versus Other Genotypes in Sporadic Pediatric Infections in Davidson County, Tennessee, USA. Clinical Infectious Diseases. 2021;73(7, 1 October):1525–1531. https://doi.org/10.1093/cid/ciaa1001
11. Zhang M., Ghosh S., Kumar M., et al. Emerging Pathogenic Unit of Vesicle-Cloaked Murine Norovirus Clusters is Resistant to Environmental Stresses and UV254 Disinfection. Environmental Science and Technology. 2021;55(9):6197–6205. (Ecotoxicology and public health April 15, 2021). Available at: https://pubs.acs.org/doi/10.1021/acs.est.1c01763.
12. Zhang M., Atlan-Bonnet N., Shen Y., et al. Waterborne human pathogenic viruses in complex microbial communities: environmental implication on virus infectivity, persistans, and disinfection. Environ. sci. and technology. 2022;56(9):5381–5389. https://doi.org/10.1021/acs.est.2c00233.
13. Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle Vaccine in an Elderly Population. Clinicaltrials. 2016. Available at: https://www.clinicaltrials.gov/ct2/show/NCT02661490 (дата обращения 29.01.2024).
14. Sherwood J., Mendelman P.M., Lloyd E., et al. Efficacy of an intramuscular bivalent norovirus GI.1/GII.4 virus-like particle vaccine candidate in healthy US adults. Vaccine. 2020;38:6442–6449.
15. Ph 1b: Safety and Immunogenicity of Ad5 Based Oral Norovirus Vaccine (VXA-NVV-104). Clinicaltrials. 2021. Available at: https://clinicaltrials.gov/ct2/show/NCT04854746h (дата обращения 29.01.2024).
16. National Vaccine Serum Institute, C. Clinical Trial to Evaluate the Recombinant Norovirus Bivalent (GI. 1/GII. 4) Vaccine (Hansenula Polymorpha). Clinicaltrials. 2021. Available at: https://clinicaltrials.gov/ct2/show/NCT04941261h.
17. On the state of sanitary and epidemiological welfare of the population in the Russian Federation in 2023: State Report. Moscow: Federal Service for Supervision of Consumer Rights Protection and Human Well-being, 2024. 364 p. (In Russ.).
18. Murata, T., Katsushima, N., Mizuta, K., et al. Prolonged norovirus shedding in infants ≤6 months of age with gastroenteritis. J. Pediatr. Infect. 2007; 26: 46–49.
19. Cannon J.L., Barclay L., Collins N.R., et al. J. Genetic and Epidemiologic Trends of Norovirus Outbreaks in the United States from 2013 2016 Emergence of Novel GII.4 Recombinant Viruses. J. Clin. Microbiol. 2017; 55: 2208. https://doi.org/10.1128/jcm.00455-17
20. MU 3.1.1.2969-11. 3.1.1. Prevention of infectious diseases. Intestinal infections. Epidemiological surveillance, laboratory diagnostics and prevention of norovirus infection. Methodological guidelines (approved by the Chief State Sanitary Doctor of the Russian Federation 15.11.2011): 25 p. (In Russ.).
21. Greig J.D., Lee M.B. A review of nosocomial norovirus outbreaks: infection control interventions found effective Epidemiology and Infection. 2012; 140(7): 1151–1160. DOI:https://doi.org/10.1017/S0950268811002731.
22. Public health and healthcare: a textbook. Ed.: V.Z. Kucherenko. M.: Mysl, 2013:81–87. (In Russ.).
23. Order of the Ministry of Health of the Russian Federation No. 182 dated 04/20/2018 «On approval of methodological recommendations on the application of standards and norms of resource provision of the population in the field of healthcare». (In Russ.). Available at: https://www.garant.ru/products/ipo/prime/doc/71844124/?ysclid=lzd4xv47kh254905549#1000
24. Endoviczkij D.A., Golovin S.V., Churikov A.V. Economic analysis of the efficiency of using the resources of medical organizations based on the performance of indicators of the use of the bed fund// Modern economy: problems and solutions. 2020;1(121):77–86 (In Russ.). DOI:10.17308/meps.2020.1/2050
Review
For citations:
Davydova M.A., Bryukhanova G.D., Gorodin V.N. Outbreak of Norovirus Infection in the Hematology Department of a Children's Multidisciplinary Hospital. Epidemiology and Vaccinal Prevention. 2024;23(6):73-82. (In Russ.) https://doi.org/10.31631/2073-3046-2024-23-6-73-82